Management of overdose includes symptomatic and supportive treatment. Supportive measures include maintenance of an adequate airway, monitoring urinary output and vital signs, and administration of intravenous fluids if necessary. The usefulness of hemodialysis in managing overdose is unknown.
DOSAGE AND ADMINISTRATION
Methocarbamol Tablets USP, 500 mg – Adults:
Initial dosage: 3 tablets q.i.d.
Maintenance dosage: 2 tablets q.i.d.
Methocarbamol Tablets USP, 750 mg – Adults:
Initial dosage: 2 tablets q.i.d.
Maintenance dosage: 1 tablet q.4h. or 2 tablets t.i.d.
Six grams a day are recommended for the first 48 to 72 hours of treatment. (For severe conditions 8 grams a day may be administered). Thereafter, the dosage can usually be reduced to approximately 4 grams a day.
Methocarbamol Tablets, USP, 500 mg are white, round, bisected tablets, debossed with LAN over 1302, supplied in bottles of 100 and 500 tablets.
100 Tablets NDC 0527-1302-01
500 Tablets NDC 0527-1302-05
Methocarbamol Tablets, USP, 750 mg are white, scored, capsule-shaped tablets debossed with LAN besides 1152, supplied in bottles of 100 and 500 tablets.
100 Tablets NDC 0527-1152-01
500 Tablets NDC 0527-1152-05
Store at controlled room temperature, between 20°C and 25°C (68°F and 77°F) [see USP Controlled Room Temperature].
Dispense in a tight container as defined in the USP with a child-resistant closure (as required).
LANNETT CO., INC.
PHILADELPHIA, PA 19136
| METHOCARBAMOL |
| METHOCARBAMOL |
|Labeler — Lannett Company, Inc.|
Revised: 06/2007 Lannett Company, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.